Walleye Capital LLC Biogen Inc. Put Options Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $1.1 Million - $1.39 Million	5,200 Added 11.3%	51,200 $11 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $2.23 Million - $2.68 Million	10,000 Added 27.78%	46,000 $11.9 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $481,270 - $543,191	-1,900 Reduced 5.01%	36,000 $9.25 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $10 Million - $11.6 Million	36,500 Added 2607.14%	37,900 $10.8 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $102,624 - $116,935	-400 Reduced 22.22%	1,400 $389,000

Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $454,392 - $552,096	1,800 New	1,800 $498,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2 Million - $2.77 Million	-9,100 Reduced 33.46%	18,100 $5.37 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $4.24 Million - $4.76 Million	19,500 Added 253.25%	27,200 $6.33 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $1.69 Million - $1.86 Million	7,700 New	7,700 $1.8 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.